Pharma News

The latest developments from pharmaceutical and biopharmaceutical companies, both innovator and generic-drug companies, and leading regulatory news.

Roche reports that it will invest CHF 120 million ($134 million) to build new facilities at its headquarters in Basel, Switzerland, as well as to make upgrades to existing production operations at Basel. The company plans to build a new...

Novartis reports that FDA has issued a Complete Response Letter (CRL) regarding the bologics license application (BLA) for RLX030 (serelaxin) for the treatment of acute heart failure, stating that further evidence on the efficacy of RLX030 is...

Takashi Shoda, current chairman and representative director of Daiichi Sankyo Company, will be stepping down and taking on a position as senior corporate advisor to the company. The move is subject to approval at the company's annual...

In ongoing litigation over the safety of its diabetes drug Actos (pioglitazone HCl), Takeda Pharmaceutical Company Limited and its wholly owned subsidiary, Takeda Pharmaceuticals U.S.A., Inc., report that in the case of the Whitlatch v. Takeda ,...

Dr. Reddy's Laboratories Ltd. reports that its board of directors has decided to have separate roles of the chairman of the company and the managing director and CEO. It has appointed Satish Reddy as chairman of the board. He...

Actavis plc has announced the proposed senior management team that will lead the specialty pharmaceutical company pending the successful close of the acquisition of Forest Laboratories, Inc., which is anticipated at...

Bristol-Myers Squibb Company and the biopharmaceutical company Celldex Therapeutics have formed a clinical trial collaboration to evaluate the safety, tolerability, and preliminary efficacy of nivolumab, Bristol-Myers Squibb's...